Edition:
India

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

10.36USD
14 Dec 2018
Change (% chg)

$0.39 (+3.91%)
Prev Close
$9.97
Open
$9.86
Day's High
$10.41
Day's Low
$9.77
Volume
125,517
Avg. Vol
69,331
52-wk High
$20.55
52-wk Low
$9.66

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.73 December 16 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 5 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.60 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 0.00 0.00 0.00 16.25
Quarter Ending Mar-19 5 6.10 29.00 0.00 --
Year Ending Dec-18 7 0.57 1.00 0.50 18.10
Year Ending Dec-19 7 43.42 135.00 9.71 110.38
Earnings (per share)
Quarter Ending Dec-18 7 -0.73 -0.67 -0.85 -0.04
Quarter Ending Mar-19 7 -0.55 0.23 -0.74 --
Year Ending Dec-18 7 -2.81 -2.74 -2.93 -1.83
Year Ending Dec-19 7 -1.64 1.52 -2.62 1.35

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.04 0.00 0.04 100.00
Quarter Ending Jun-18 0.04 0.50 0.46 1,150.00
Quarter Ending Mar-18 0.05 0.00 0.05 100.00
Quarter Ending Dec-17 0.17 0.00 0.17 100.00
Quarter Ending Sep-17 0.17 0.30 0.13 79.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.00 0.00 0.00 0.41 16.25
Quarter Ending Mar-19 6.10 6.12 7.28 13.32 --
Year Ending Dec-18 0.57 0.50 0.50 0.95 18.10
Year Ending Dec-19 43.42 53.80 55.29 60.83 110.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 1 0 1
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 1 0 2
Earnings